(Q40956717)

25 September 2017

title

Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity (English)

1 reference

25 September 2017

0 references

1 reference

Zou L

1

1 reference

25 September 2017

Jankovic J

2

1 reference

25 September 2017

Rowe DB

3

1 reference

25 September 2017

Xie W

4

1 reference

25 September 2017

Appel SH

5

1 reference

25 September 2017

Le W

6

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

25 September 2017

1 reference

25 September 2017

volume

64

1 reference

25 September 2017

issue

15

1 reference

25 September 2017

page(s)

1275-1285

1 reference

Rat brain binding sites for pramipexole, a clinically useful D3-preferring dopamine agonist

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

Neuroprotective effects of the dopamine agonists pramipexole and bromocriptine in 3-acetylpyridine-treated rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

Dopamine- and L-beta-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

Dopamine-induced programmed cell death in mouse thymocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

L-dopa cytotoxicity to PC12 cells in culture is via its autoxidation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

Dopamine, 6-hydroxydopamine, iron, and dioxygen--their mutual interactions and possible implication in the development of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

A radical hypothesis for neurodegeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

Comparison of the neurotoxicity of dihydroxyphenylalanine stereoisomers in cultured dopamine neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

Neurotoxicity of levodopa on catecholamine-rich neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

The detrimental effect of levodopa on behavioral efficacy of fetal dopamine neuron grafts in rats is reversible following prolonged withdrawal of chronic dosing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

Scavenging effects of dopamine agonists on nitric oxide radicals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

Bcl-2 functions in an antioxidant pathway to prevent apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

The proto-oncogene Bcl-2 and its role in regulating apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

Protection of PC12 cells glutathione peroxidase in L-DOPA induced cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

An in vitro bacterial model of cytotoxicity to living cells caused by dopamine and 6-hydroxydopamine oxidation at physiological pH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: mechanisms of neuroprotective treatment against oxidative stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

Suppressive effect of L-dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900062-4

10.1016/S0024-3205(99)00062-4

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference